Phase I/II open label, multicentre, single arm study assessing neoadjuvant combination therapy of vinflunine with cisplatin followed by radical cystectomy in patients with bladder cancer.
Phase of Trial: Phase I/II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Cisplatin (Primary) ; Vinflunine (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Acronyms JaNEO
- 08 Feb 2017 Status changed from not yet recruiting to recruiting.
- 09 Dec 2016 New trial record
- 11 Oct 2016 Trial design presented at the 41st European Society for Medical Oncology Congress